205 related articles for article (PubMed ID: 37922327)
41. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
[TBL] [Abstract][Full Text] [Related]
42. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone.
Roca H; Jones JD; Purica MC; Weidner S; Koh AJ; Kuo R; Wilkinson JE; Wang Y; Daignault-Newton S; Pienta KJ; Morgan TM; Keller ET; Nör JE; Shea LD; McCauley LK
J Clin Invest; 2018 Jan; 128(1):248-266. PubMed ID: 29202471
[TBL] [Abstract][Full Text] [Related]
43. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
[TBL] [Abstract][Full Text] [Related]
44. mda-9/syntenin: recent insights into a novel cell signaling and metastasis-associated gene.
Sarkar D; Boukerche H; Su ZZ; Fisher PB
Pharmacol Ther; 2004 Nov; 104(2):101-15. PubMed ID: 15518882
[TBL] [Abstract][Full Text] [Related]
45. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin.
Talukdar S; Pradhan AK; Bhoopathi P; Shen XN; August LA; Windle JJ; Sarkar D; Furnari FB; Cavenee WK; Das SK; Emdad L; Fisher PB
Autophagy; 2018; 14(10):1845-1846. PubMed ID: 30118375
[TBL] [Abstract][Full Text] [Related]
46. EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis.
Li L; Ameri AH; Wang S; Jansson KH; Casey OM; Yang Q; Beshiri ML; Fang L; Lake RG; Agarwal S; Alilin AN; Xu W; Yin J; Kelly K
Oncogene; 2019 Aug; 38(35):6241-6255. PubMed ID: 31312026
[TBL] [Abstract][Full Text] [Related]
47. Melanoma metastasis is associated with enhanced expression of the syntenin gene.
Helmke BM; Polychronidis M; Benner A; Thome M; Arribas J; Deichmann M
Oncol Rep; 2004 Aug; 12(2):221-8. PubMed ID: 15254681
[TBL] [Abstract][Full Text] [Related]
48. Syntenin increases the invasiveness of small cell lung cancer cells by activating p38, AKT, focal adhesion kinase and SP1.
Kim WY; Jang JY; Jeon YK; Chung DH; Kim YG; Kim CW
Exp Mol Med; 2014 Apr; 46(4):e90. PubMed ID: 24722482
[TBL] [Abstract][Full Text] [Related]
49. Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.
Bhoopathi P; Pradhan AK; Bacolod MD; Emdad L; Sarkar D; Das SK; Fisher PB
Oncogene; 2019 Oct; 38(41):6781-6793. PubMed ID: 31406249
[TBL] [Abstract][Full Text] [Related]
50. Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.
Hughes RM; Simons BW; Khan H; Miller R; Kugler V; Torquato S; Theodros D; Haffner MC; Lotan T; Huang J; Davicioni E; An SS; Riddle RC; Thorek DLJ; Garraway IP; Fertig EJ; Isaacs JT; Brennen WN; Park BH; Hurley PJ
Cancer Res; 2019 Jul; 79(14):3636-3650. PubMed ID: 31123087
[TBL] [Abstract][Full Text] [Related]
51. Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK/MSK1/Elk-1/snail signaling pathway.
Hsu YL; Hou MF; Kuo PL; Huang YF; Tsai EM
Oncogene; 2013 Sep; 32(37):4436-47. PubMed ID: 23045282
[TBL] [Abstract][Full Text] [Related]
52. Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche.
Correa D; Somoza RA; Lin P; Schiemann WP; Caplan AI
Int J Cancer; 2016 Jan; 138(2):417-27. PubMed ID: 26235173
[TBL] [Abstract][Full Text] [Related]
53. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.
Uehara H; Kim SJ; Karashima T; Shepherd DL; Fan D; Tsan R; Killion JJ; Logothetis C; Mathew P; Fidler IJ
J Natl Cancer Inst; 2003 Mar; 95(6):458-70. PubMed ID: 12644539
[TBL] [Abstract][Full Text] [Related]
54. Syntenin-1-mediated small extracellular vesicles promotes cell growth, migration, and angiogenesis by increasing onco-miRNAs secretion in lung cancer cells.
Kim O; Hwangbo C; Tran PT; Lee JH
Cell Death Dis; 2022 Feb; 13(2):122. PubMed ID: 35136055
[TBL] [Abstract][Full Text] [Related]
55. The Multifunctional Protein Syntenin-1: Regulator of Exosome Biogenesis, Cellular Function, and Tumor Progression.
Lee KM; Seo EC; Lee JH; Kim HJ; Hwangbo C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298370
[TBL] [Abstract][Full Text] [Related]
56. In vitro model of metastasis to bone marrow mediates prostate cancer castration resistant growth through paracrine and extracellular matrix factors.
Lescarbeau RM; Seib FP; Prewitz M; Werner C; Kaplan DL
PLoS One; 2012; 7(8):e40372. PubMed ID: 22870197
[TBL] [Abstract][Full Text] [Related]
57. Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.
Lee YC; Gajdosik MS; Josic D; Clifton JG; Logothetis C; Yu-Lee LY; Gallick GE; Maity SN; Lin SH
Mol Cell Proteomics; 2015 Mar; 14(3):471-83. PubMed ID: 25527621
[TBL] [Abstract][Full Text] [Related]
58. CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.
Sorrentino C; D'Antonio L; Ciummo SL; Fieni C; Landuzzi L; Ruzzi F; Vespa S; Lanuti P; Lotti LV; Lollini PL; Di Carlo E
J Hematol Oncol; 2022 Oct; 15(1):145. PubMed ID: 36224639
[TBL] [Abstract][Full Text] [Related]
59. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines.
Koo TH; Lee JJ; Kim EM; Kim KW; Kim HD; Lee JH
Oncogene; 2002 Jun; 21(26):4080-8. PubMed ID: 12037664
[TBL] [Abstract][Full Text] [Related]
60. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
